Collamedix Inc
CollaMedix Inc., founded in 2018, specializes in the commercialization of innovative collagen-based electrocompaction technology originally developed at Case Western Reserve University. The company, led by experienced medical device entrepreneurs and supported by a team of experts, aims to enhance patient outcomes through safe and effective biomaterial solutions.
With a focus on developing breakthrough medical devices for soft tissue repair and augmentation, CollaMedix has successfully secured $8 million in grant funding from esteemed organizations such as the National Science Foundation and the National Institutes of Health. The company's unique electrocompacted collagen products are designed to deliver significant clinical benefits for female pelvic health and beyond.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


